Cargando…
Mass-Cytometry-Based Quantification of Global Histone Post-Translational Modifications at Single-Cell Resolution Across Peripheral Immune Cells in IBD
BACKGROUND AND AIMS: Current understanding of histone post-translational modifications [histone modifications] across immune cell types in patients with inflammatory bowel disease [IBD] during remission and flare is limited. The present study aimed to quantify histone modifications at a single-cell...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155749/ https://www.ncbi.nlm.nih.gov/pubmed/36571819 http://dx.doi.org/10.1093/ecco-jcc/jjac194 |
_version_ | 1785036397311164416 |
---|---|
author | Bai, Lawrence Dermadi, Denis Kalesinskas, Laurynas Dvorak, Mai Chang, Sarah E Ganesan, Ananthakrishnan Rubin, Samuel J S Kuo, Alex Cheung, Peggie Donato, Michele Utz, Paul J Habtezion, Aida Khatri, Purvesh |
author_facet | Bai, Lawrence Dermadi, Denis Kalesinskas, Laurynas Dvorak, Mai Chang, Sarah E Ganesan, Ananthakrishnan Rubin, Samuel J S Kuo, Alex Cheung, Peggie Donato, Michele Utz, Paul J Habtezion, Aida Khatri, Purvesh |
author_sort | Bai, Lawrence |
collection | PubMed |
description | BACKGROUND AND AIMS: Current understanding of histone post-translational modifications [histone modifications] across immune cell types in patients with inflammatory bowel disease [IBD] during remission and flare is limited. The present study aimed to quantify histone modifications at a single-cell resolution in IBD patients during remission and flare and how they differ compared to healthy controls. METHODS: We performed a case-control study of 94 subjects [83 IBD patients and 11 healthy controls]. IBD patients had either ulcerative colitis [n = 38] or Crohn’s disease [n = 45] in clinical remission or flare. We used epigenetic profiling by time-of-flight [EpiTOF] to investigate changes in histone modifications within peripheral blood mononuclear cells from IBD patients. RESULTS: We discovered substantial heterogeneity in histone modifications across multiple immune cell types in IBD patients. They had a higher proportion of less differentiated CD34(+) haematopoietic progenitors, and a subset of CD56(bright) natural killer [NK] cells and γδ T cells characterized by distinct histone modifications associated with gene transcription. The subset of CD56(bright) NK cells had increases in several histone acetylations. An epigenetically defined subset of NK cells was associated with higher levels of C-reactive protein in peripheral blood. CD34(+) monocytes from IBD patients had significantly decreased cleaved H3T22, suggesting they were epigenetically primed for macrophage differentiation. CONCLUSION: We describe the first systems-level quantification of histone modifications across immune cells from IBD patients at a single-cell resolution, revealing the increased epigenetic heterogeneity that is not possible with traditional ChIP-seq profiling. Our data open new directions in investigating the association between histone modifications and IBD pathology using other epigenomic tools. |
format | Online Article Text |
id | pubmed-10155749 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-101557492023-05-04 Mass-Cytometry-Based Quantification of Global Histone Post-Translational Modifications at Single-Cell Resolution Across Peripheral Immune Cells in IBD Bai, Lawrence Dermadi, Denis Kalesinskas, Laurynas Dvorak, Mai Chang, Sarah E Ganesan, Ananthakrishnan Rubin, Samuel J S Kuo, Alex Cheung, Peggie Donato, Michele Utz, Paul J Habtezion, Aida Khatri, Purvesh J Crohns Colitis Original Articles BACKGROUND AND AIMS: Current understanding of histone post-translational modifications [histone modifications] across immune cell types in patients with inflammatory bowel disease [IBD] during remission and flare is limited. The present study aimed to quantify histone modifications at a single-cell resolution in IBD patients during remission and flare and how they differ compared to healthy controls. METHODS: We performed a case-control study of 94 subjects [83 IBD patients and 11 healthy controls]. IBD patients had either ulcerative colitis [n = 38] or Crohn’s disease [n = 45] in clinical remission or flare. We used epigenetic profiling by time-of-flight [EpiTOF] to investigate changes in histone modifications within peripheral blood mononuclear cells from IBD patients. RESULTS: We discovered substantial heterogeneity in histone modifications across multiple immune cell types in IBD patients. They had a higher proportion of less differentiated CD34(+) haematopoietic progenitors, and a subset of CD56(bright) natural killer [NK] cells and γδ T cells characterized by distinct histone modifications associated with gene transcription. The subset of CD56(bright) NK cells had increases in several histone acetylations. An epigenetically defined subset of NK cells was associated with higher levels of C-reactive protein in peripheral blood. CD34(+) monocytes from IBD patients had significantly decreased cleaved H3T22, suggesting they were epigenetically primed for macrophage differentiation. CONCLUSION: We describe the first systems-level quantification of histone modifications across immune cells from IBD patients at a single-cell resolution, revealing the increased epigenetic heterogeneity that is not possible with traditional ChIP-seq profiling. Our data open new directions in investigating the association between histone modifications and IBD pathology using other epigenomic tools. Oxford University Press 2022-12-26 /pmc/articles/PMC10155749/ /pubmed/36571819 http://dx.doi.org/10.1093/ecco-jcc/jjac194 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Articles Bai, Lawrence Dermadi, Denis Kalesinskas, Laurynas Dvorak, Mai Chang, Sarah E Ganesan, Ananthakrishnan Rubin, Samuel J S Kuo, Alex Cheung, Peggie Donato, Michele Utz, Paul J Habtezion, Aida Khatri, Purvesh Mass-Cytometry-Based Quantification of Global Histone Post-Translational Modifications at Single-Cell Resolution Across Peripheral Immune Cells in IBD |
title | Mass-Cytometry-Based Quantification of Global Histone Post-Translational Modifications at Single-Cell Resolution Across Peripheral Immune Cells in IBD |
title_full | Mass-Cytometry-Based Quantification of Global Histone Post-Translational Modifications at Single-Cell Resolution Across Peripheral Immune Cells in IBD |
title_fullStr | Mass-Cytometry-Based Quantification of Global Histone Post-Translational Modifications at Single-Cell Resolution Across Peripheral Immune Cells in IBD |
title_full_unstemmed | Mass-Cytometry-Based Quantification of Global Histone Post-Translational Modifications at Single-Cell Resolution Across Peripheral Immune Cells in IBD |
title_short | Mass-Cytometry-Based Quantification of Global Histone Post-Translational Modifications at Single-Cell Resolution Across Peripheral Immune Cells in IBD |
title_sort | mass-cytometry-based quantification of global histone post-translational modifications at single-cell resolution across peripheral immune cells in ibd |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155749/ https://www.ncbi.nlm.nih.gov/pubmed/36571819 http://dx.doi.org/10.1093/ecco-jcc/jjac194 |
work_keys_str_mv | AT bailawrence masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd AT dermadidenis masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd AT kalesinskaslaurynas masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd AT dvorakmai masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd AT changsarahe masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd AT ganesanananthakrishnan masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd AT rubinsamueljs masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd AT kuoalex masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd AT cheungpeggie masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd AT donatomichele masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd AT utzpaulj masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd AT habtezionaida masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd AT khatripurvesh masscytometrybasedquantificationofglobalhistoneposttranslationalmodificationsatsinglecellresolutionacrossperipheralimmunecellsinibd |